View frequently asked questions
The Drug Use Review (DUR) program consists of prospective drug review, retrospective drug use review, and an educational program. Included but not limited to the following are ongoing interventions for physicians and pharmacists, targeted toward therapy problems or individuals identified in the course of retrospective drug use reviews, including intensified review or monitoring of selected prescribers or dispensers and re-evaluation of interventions after an appropriate period of time to determine if the intervention improved the quality of drug therapy, to evaluate the success of the interventions and make modifications as necessary. The goal is to ensure appropriate drug therapy, while permitting sufficient professional prerogatives to allow for individualized drug therapy. Med-QUEST is ultimately responsible for ensuring that the DUR program is operational. The agency has the authority to accept or reject the recommendations or decisions of the DUR Board.